Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

METHOCARBAMOL vs METHYLENE BLUE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

METHOCARBAMOL vs METHYLENE BLUE: Safety Overview

Metric METHOCARBAMOL METHYLENE BLUE
Total FAERS Reports 2,201 846
Deaths Reported 546 165
Death Rate 24.8% 19.5%
Hospitalizations 816 536
Average Patient Age 49.7 yrs 48.0 yrs
% Female Patients 68.7% 49.8%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 8, 2016
Manufacturer PD-Rx Pharmaceuticals, Inc. Zydus Pharmaceuticals USA Inc.
Route ORAL INTRAVENOUS
Marketing Status Discontinued Prescription